A new role of Pro-73 of p47phox in the activation of neutrophil NADPH oxidase

https://doi.org/10.1016/S0003-9861(03)00296-0Get rights and content

Abstract

The PX domain of p47phox is thought to be involved in autoinhibition. However, when the domain was deleted, the ability to activate the phagocyte NADPH oxidase was markedly diminished. We have mutated the proline-rich region of the PX domain and examined the mutants for the ability to activate. Substitution of Gln for Pro-73 of p47phox(1–286) (P73Q) resulted in a considerably lower activity than the wild type and P73Q had a much lower affinity for the oxidase complex. Whereas, Gln substitution for Pro-76 (P76Q) showed a slightly enhanced activation and the mutant had a slightly higher affinity for the complex than the wild type. Affinity for p67phox(1–210) was slightly decreased either by P73Q or P76Q. Optimal SDS concentration for the activation was lowered by these mutations. Binding of PX domain with phosphatidylinositol-3,4-bisphosphate was diminished by P73Q mutation. The results in this study suggest that Pro-73 has a role in interaction with the catalytic component cytochrome b558.

Section snippets

Materials

Glutathione–Sepharose, CM-Sepharose FF, pGEX-6P, and Escherichia coli BL21 strain were purchased from Amersham Biosciences (Piscataway, NJ). Oligonucleotide primers for PCR and mutations were synthesized by the same manufacturer. BamHI and EcoRI were obtained from Toyobo (Tokyo, Japan). Thrombin and cytochrome c were purchased from Sigma–Aldrich (St. Louis, MO). Diisopropyl fluorophosphate was obtained from Wako Pure Chemicals (Osaka, Japan). GTP and FAD were purchased from Nacalai Tesque,

Requirement of PX domain for activation

Two groups reported that deletion of PX domain diminishes the ability of activation [18], [19]. However, as their deletions included additional 25 amino acid residues following the PX domain, actual role of the PX domain has not been clarified. Here, we made a p47phox fragment that lacks the exact region of the PX domain (assigned as ΔPX) and examined its ability to activate (Table 1). ΔPX showed a considerably lower ability to activate (33%). When the deletion was extended to residue 153

Discussion

A truncated form of p47phox (1–286) (p47N) is able to produce full activation of NADPH oxidase in a cell-free reconstitution system [19], [20], indicating that p47N contains all the domains essential for the activation. The p47N fragment possesses a PX domain and two SH3 domains with a connecting region in-between. The SH3 domains are thought to be involved in interaction with p22phox when unmasked. The PX domain is reportedly involved in negative regulation by interacting with one of the

Acknowledgements

This work was supported in part by a grant (13480297) for scientific research from the Ministry of Education, Science, Sports and Culture of Japan. We are grateful to Shuhei Kobayashi, Mamoru Tanaka, Yasuaki Komeima, Tetsutaro Kai, and Kyoji Watanabe for their excellent technical assistance and to Drs. Koichi Tanaka, Yaeta Endo, and Keiichi Kato (Department of Applied Chemistry, Ehime University) for their discussions and instruments. We are grateful to Drs. Chang-Hoon Han (Department of

References (48)

  • B.M Babior

    Blood

    (1984)
  • F Rossi

    Biochim. Biophys. Acta

    (1986)
  • P Bellavite

    Free Radic. Biol. Med.

    (1988)
  • A.J Thrasher et al.

    Biochim. Biophys. Acta

    (1994)
  • B.M Babior

    Blood

    (1999)
  • M Tamura et al.

    Biochim. Biophys. Acta

    (2001)
  • M Tamura et al.

    Biochem. Biophys. Res. Commun.

    (2000)
  • I de Mendez et al.

    J. Biol. Chem.

    (1994)
  • P Finan et al.

    J. Biol. Chem.

    (1994)
  • F.R DeLeo et al.

    J. Biol. Chem.

    (1996)
  • T Ito et al.

    FEBS Lett.

    (1996)
  • K Hata et al.

    J. Biol. Chem.

    (1998)
  • K Ebisu et al.

    J. Biol. Chem.

    (2001)
  • C.H Han et al.

    J. Biol. Chem.

    (1998)
  • A Shiose et al.

    J. Biol. Chem.

    (2000)
  • T Ago et al.

    Biochem. Biophys. Res. Commun.

    (2001)
  • Y Zhan et al.

    J. Biol. Chem.

    (2002)
  • M Tamura et al.

    J. Biol. Chem.

    (1992)
  • H Fujii et al.

    Biochim. Biophys. Acta

    (1992)
  • M Tamura et al.

    J. Biol. Chem.

    (1988)
  • D Rotrosen et al.

    J. Biol. Chem.

    (1990)
  • A Nakanishi et al.

    J. Biol. Chem.

    (1992)
  • A.R Cross et al.

    J. Biol. Chem.

    (1995)
  • L.S Yoshida et al.

    J. Biol. Chem.

    (1998)
  • Cited by (7)

    • Atypical membrane-embedded phosphatidylinositol 3,4-bisphosphate (PI(3,4)P<inf>2</inf>)-binding site on p47<sup>phox</sup> phox homology (PX) domain revealed by NMR

      2012, Journal of Biological Chemistry
      Citation Excerpt :

      Interestingly, our results can provide a rationale for the in vivo behaviors of two mutants, those of Pro-73 and Arg-70, that are within the presently identified C16-PI(3,4)P2-containing membrane-interacting interface. It has been reported that the mutation Pro-73 abrogates phosphoinositide recognition and interferes with the in vitro activity of NADPH oxidase (46), while the mutation Arg-70 prevents membrane translocation in HEK293 cells (47). Our experiments revealed that PA and soluble C4-PI(3,4)P2 competitively bind to the p47phox domain (Fig. 4).

    View all citing articles on Scopus
    View full text